Upper-airway obstruction and prolonged recovery from anesthesia following intranasal clotrimazole administration.
A 16-month-old Labrador retriever was presented for evaluation and treatment of nasal aspergillosis. Intranasal clotrimazole was administered to treat the condition. The dog was anesthetized on two occasions to facilitate drug administration. Following the first treatment, the dog developed mild pharyngitis but no other complications. Inflammation and edema of the pharynx resulted in upper-airway obstruction following the second treatment. Pentobarbital sedation was used to maintain the endotracheal tube until the obstruction was relieved. Recovery following sedation was extremely prolonged. This case illustrates two adverse drug reactions: severe pharyngitis and edema (probably a result of the vehicles present in the clotrimazole formulation) and prolonged recovery (possibly the result of microsomal enzyme inhibition by the clotrimazole).
Caulkett
N
N
Department of Veterinary Anesthesiology, Radiology, and Surgery, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.
Lew
L
L
Fries
C
C
D000281:Administration, Intranasal; D000402:Airway Obstruction / Q000139:chemically induced / Q000503:physiopathology / Q000662:veterinary*; D000762:Anesthesia Recovery Period; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000662:veterinary; D003022:Clotrimazole / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004283:Dog Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D004285:Dogs; D004347:Drug Interactions; D004487:Edema / Q000139:chemically induced / Q000503:physiopathology / Q000662:veterinary; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000494:pharmacology; D007262:Infusions, Intravenous; D008297:Male; D010424:Pentobarbital / Q000008:administration & dosage / Q000494:pharmacology; D010608:Pharyngeal Diseases / Q000139:chemically induced / Q000503:physiopathology / Q000662:veterinary*; D010612:Pharyngitis / Q000139:chemically induced / Q000503:physiopathology / Q000662:veterinary*; D012119:Respiration / Q000187:drug effects / Q000502:physiology
D000935:Antifungal Agents; D006993:Hypnotics and Sedatives; D003022:Clotrimazole; D010424:Pentobarbital